P Borsotti

Author PubWeight™ 14.23^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	The microtubule-affecting drug paclitaxel has antiangiogenic activity.	Clin Cancer Res	1996	2.57
2	Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo.	Am J Pathol	2000	2.05
3	Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4.	Leukemia	2003	1.15
4	Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases.	J Natl Cancer Inst	1995	1.13
5	The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor.	Cell Growth Differ	1997	1.07
6	p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis.	Oncogene	2001	1.02
7	BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity.	Clin Cancer Res	1999	0.99
8	Antiangiogenic activity of aplidine, a new agent of marine origin.	Br J Cancer	2004	0.97
9	Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions.	J Pathol	1999	0.94
10	Posttranscriptional stimulation of endothelial cell matrix metalloproteinases 2 and 1 by endothelioma cells.	Exp Cell Res	2000	0.93
11	Inhibition of matrix metalloproteinases by over-expression of tissue inhibitor of metalloproteinase-2 inhibits the growth of experimental hemangiomas.	Int J Cancer	2001	0.81
12	Effect of all trans-retinoic acid (ATRA) on the adhesive and motility properties of acute promyelocytic leukemia cells.	Int J Cancer	1997	0.77